TUCSON, Ariz., Nov. 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) an innovator of rapid in vitro diagnostics in microbiology, announced the signing of a collaboration and ...

TUCSON, Ariz., Jan. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes and ...

Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly. Sepsis is a potentially fatal response from the body to an infection, and 1.7 ...

This new testing platform will speed up health checks by determining whether asymptomatic people have COVID-19 antibodies in 30 minutes. On Tuesday, the two companies announced that the Food and Drug ...

Accelerate Diagnostics (NASDAQ:AXDX) said Friday it priced an underwritten public offering of units and a concurrent private placement to raise up to $15 million. Shares -33.33% at $1.07 in early ...

TUCSON, Ariz., Oct. 30, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) announced today that management will host a conference call on Thursday, November 9, 2023, at 4:30 p.m. Eastern Time to ...

Accelerate Diagnostics ( (AXDX)) has released its Q3 earnings. Here is a breakdown of the information Accelerate Diagnostics presented to its investors. Accelerate Diagnostics, Inc. is a company ...

BD (Becton, Dickinson and Co.) announced Aug. 15 a commercial collaboration under which the Franklin Lakes-based company will offer Accelerate Diagnostics Inc.’s rapid tests through its global sales ...

In response toreceivingFDA marketing authorization for two products, shares of Accelerate Diagnostics (NASDAQ: AXDX), a company focused onthe rapid diagnosis of infectious diseases, rose by 11% as of ...

TUCSON, Ariz., Nov. 9, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced preliminary financial results for the third quarter for the period ended September 30, 2021, ...

Accelerate Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Accelerate ...